SOLESENCE, INC. — Director's Dealing 2024

Jun 25, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2024-06-21

Reporting Person: Cureton Kevin (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-21	Common Stock	P	100	$1.45	Acquired	175921	Direct
2024-06-21	Common Stock	P	100	$1.4625	Acquired	176021	Direct
2024-06-21	Common Stock	P	800	$1.4768	Acquired	176821	Direct
2024-06-21	Common Stock	P	1000	$1.4885	Acquired	177821	Direct
2024-06-21	Common Stock	P	5100	$1.49	Acquired	182921	Direct
2024-06-24	Common Stock	P	4575	$1.498	Acquired	187496	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to purchase)	$0.44	2025-02-18	Common Stock (50000)	0	Direct
Common Stock (right to purchase)	$0.42	2026-02-23	Common Stock (43500)	43500	Direct
Common Stock (right to purchase)	$0.68	2027-02-21	Common Stock (50000)	50000	Direct
Common Stock (right to purchase)	$0.82	2028-05-23	Common Stock (80000)	80000	Direct
Common Stock (right to purchase)	$0.51	2029-05-22	Common Stock (16500)	16500	Direct
Common Stock (right to purchase)	$0.45	2027-06-18	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$4.17	2028-12-28	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$1.165	2029-12-20	Common Stock (72000)	72000	Direct
Common Stock (right to purchase)	$0.61	2030-12-27	Common Stock (12600)	12600	Direct